NYHA Class III Heart Failure Clinical Trial
Official title:
Bioimpedance Spectroscopy Compared to CardioMEMS™ Determined Pulmonary Artery Pressure Measurements
Comparison of changes in diastolic pulmonary artery pressure as measured by CardioMEMS™ to impedance parameters as measured by ImpediMed's BIS technology.
This is a prospective, single-arm, observational, non-randomized clinical study that will enroll patients with heart failure who have had a CardioMEMS™ device implanted to monitor their diastolic pulmonary artery pressure. The study will recruit and enroll ten participants from the Scripps Clinic. Participants will be monitored 3 times a week for a period of 4 weeks. At each monitoring visit, the patient's diastolic pulmonary artery pressure will be measured by CardioMEMS™ and the ImpediMed's BIS technology. Participant's vital signs and weight will also be taken at each monitoring visit. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01381172 -
Evaluate Safety and Efficacy of the OPTIMIZER® System in Subjects With Moderate-to-Severe Heart Failure: FIX-HF-5C
|
N/A | |
| Completed |
NCT01162707 -
Wireless, Intermittent Monitoring of Right Heart Pressures in HF
|
N/A | |
| Completed |
NCT02939053 -
Correlation of SOZO BIS Measures With CardioMEMS PA Pressure
|